社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
TradeLegend
IP属地:未知
+关注
帖子 · 134
帖子 · 134
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
TradeLegend
TradeLegend
·
2021-12-21
🤑
非常抱歉,此主贴已删除
看
3,607
回复
2
点赞
4
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-20
🤑
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>
The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>
看
3,062
回复
3
点赞
6
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-18
🤑
DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>
DaVita Board of Directors increased the authorization under the existing share repurchase program b
DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>
看
2,579
回复
2
点赞
5
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-17
🤑
非常抱歉,此主贴已删除
看
3,397
回复
1
点赞
3
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-16
🤑
All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>
The U.S. central bank charts a completely new course to attack inflation rather than continue to wai
All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>
看
3,827
回复
3
点赞
6
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-15
🤑
非常抱歉,此主贴已删除
看
3,827
回复
1
点赞
4
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-14
🤑
非常抱歉,此主贴已删除
看
3,311
回复
1
点赞
3
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-13
🤑
Stock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote>
U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank dec
Stock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote>
看
3,697
回复
2
点赞
2
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-13
🤑
非常抱歉,此主贴已删除
看
3,443
回复
3
点赞
7
编组 21备份 2
分享
举报
TradeLegend
TradeLegend
·
2021-12-11
🤑
Tesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote>
Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outs
Tesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote>
看
4,004
回复
1
点赞
3
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3565930395680990","uuid":"3565930395680990","gmtCreate":1602836610802,"gmtModify":1706620606114,"name":"TradeLegend","pinyin":"tradelegend","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":7,"tweetSize":134,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.53%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":693599866,"gmtCreate":1640047130884,"gmtModify":1640047131033,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693599866","repostId":"1184187118","repostType":4,"isVote":1,"tweetType":1,"viewCount":3607,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693069194,"gmtCreate":1639930012033,"gmtModify":1639930012195,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/693069194","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=zh_CN&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块,涨幅约为2.5%,主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨,而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中,<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司,溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势,本周上涨约20.7%,有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗,股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时,这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后,该公司每周上涨约25.2%,使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时,Vir Biotechnology(纳斯达克股票代码:VIR)飙升约23.7%,成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克(纽约证券交易所股票代码:GSK)合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有,<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家:<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻,再次提高了COVID-19疫苗的销售指引,因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势,<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%,创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中,两家新IPO的生物技术公司Instil Bio(纳斯达克股票代码:TIL)和Exscientia(纳斯达克股票代码:EXAI)脱颖而出,尽管它们在华尔街获得了良好的评级,但分别下跌了19.3%和约13.5%。与此同时,处方药比价平台运营商GoodRx Holdings(纳斯达克股票代码:GDRX)股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的,<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>,暴跌约13.1%,受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics(纳斯达克股票代码:ALLO)在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋,其中包括Cathie Wood的Ark Investment Management,该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-19 11:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块,涨幅约为2.5%,主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨,而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中,<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司,溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势,本周上涨约20.7%,有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗,股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时,这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后,该公司每周上涨约25.2%,使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时,Vir Biotechnology(纳斯达克股票代码:VIR)飙升约23.7%,成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克(纽约证券交易所股票代码:GSK)合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有,<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家:<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻,再次提高了COVID-19疫苗的销售指引,因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势,<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%,创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中,两家新IPO的生物技术公司Instil Bio(纳斯达克股票代码:TIL)和Exscientia(纳斯达克股票代码:EXAI)脱颖而出,尽管它们在华尔街获得了良好的评级,但分别下跌了19.3%和约13.5%。与此同时,处方药比价平台运营商GoodRx Holdings(纳斯达克股票代码:GDRX)股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的,<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>,暴跌约13.1%,受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics(纳斯达克股票代码:ALLO)在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋,其中包括Cathie Wood的Ark Investment Management,该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ORCL":"甲骨文","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","CERN":"美国塞纳","ARNA":"阿里那","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","PFE":"辉瑞","BK4568":"美国抗疫概念"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals dominated with a ~83.8% rise after Pfizer agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle for the electronic-medical-records company.\nVaccine developer, Novavax jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"PFE":0.9,"CERN":0.9,"ARNA":0.9,"ORCL":0.9}},"isVote":1,"tweetType":1,"viewCount":3062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699270807,"gmtCreate":1639824405751,"gmtModify":1639824405859,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699270807","repostId":"1189235922","repostType":4,"repost":{"id":"1189235922","kind":"news","pubTimestamp":1639809269,"share":"https://www.laohu8.com/m/news/1189235922?lang=zh_CN&edition=full","pubTime":"2021-12-18 14:34","market":"us","language":"en","title":"DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189235922","media":"Seeking Alpha","summary":"DaVita Board of Directors increased the authorization under the existing share repurchase program b","content":"<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级,他写道:“该公司似乎被高估,该公司未来面临几项挑战。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-18 14:34</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级,他写道:“该公司似乎被高估,该公司未来面临几项挑战。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DVA":"达维塔保健"},"source_url":"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189235922","content_text":"DaVita Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .\nSome bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'","news_type":1,"symbols_score_info":{"DVA":0.9}},"isVote":1,"tweetType":1,"viewCount":2579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690450573,"gmtCreate":1639703743619,"gmtModify":1639703743744,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690450573","repostId":"2192194909","repostType":4,"isVote":1,"tweetType":1,"viewCount":3397,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690059971,"gmtCreate":1639615627130,"gmtModify":1639615627236,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690059971","repostId":"1172070133","repostType":4,"repost":{"id":"1172070133","kind":"news","pubTimestamp":1639621250,"share":"https://www.laohu8.com/m/news/1172070133?lang=zh_CN&edition=full","pubTime":"2021-12-16 10:20","market":"us","language":"en","title":"All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172070133","media":"MarketWatch","summary":"The U.S. central bank charts a completely new course to attack inflation rather than continue to wai","content":"<p>The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out</p><p><blockquote>美联储制定了一条全新的路线来打击通胀,而不是继续等待通胀结束</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ba1b24817095f66e1cbf69b3dd7a4ad8\" tg-width=\"700\" tg-height=\"399\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.</p><p><blockquote>美联储周三会议的重大消息并不是它将停止购买债券来刺激经济,也不是它现在暗示将在2022年三次上调基准贷款利率。过去一个月,美联储官员已经充分传达了这些短期政策决定。</blockquote></p><p> No, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.</p><p><blockquote>不,最令人惊讶的是,庞大的、厌恶变革的美联储对通胀的看法发生了180度的转变。</blockquote></p><p> The Fed’s statement Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.</p><p><blockquote>美联储周三的声明和附带的材料表明,鸽派——普遍认为通胀风险被夸大的政策制定者——已经完全投降。现在每个人都是鹰。美联储已经没有鸽派了。</blockquote></p><p> Fed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.</p><p><blockquote>美联储货币政策制定者一致认为,对抗通胀是他们的首要任务。他们可能在策略或时机上存在分歧,但在尽快战胜通胀的策略上却没有分歧。美联储处于战争状态,通胀是敌人。</blockquote></p><p> For 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.</p><p><blockquote>30年来,鸽派一直是对的:通货膨胀不是经济的最大威胁;失业是。鸽派打了一场最终成功的战斗,迫使美联储考虑失业给社会和经济留下的许多个人带来的非常真实的成本。</blockquote></p><p> But now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.</p><p><blockquote>但现在,冠状病毒大流行的影响甚至迫使鸽派接受通胀是比失业更大的威胁。对于一个不喜欢变化的机构来说,这是一个巨大的变化。</blockquote></p><p> How do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.</p><p><blockquote>我们怎么知道鸽子已经变成鹰了?看看点阵图,这是美联储每三个月发布一次的图表,显示了每个货币政策制定者对未来几年底联邦基金利率水平的匿名个人预测。</blockquote></p><p> Most analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.</p><p><blockquote>大多数分析师正确地关注来年的预测中值,但我想将您的注意力简要地转移到异常值(美联储最鹰派和鸽派成员)的中期预测上,以显示战场有多大自11月10日可怕的消费者价格指数数据以来,美联储内部发生了变化。那份报告改变了美联储的一切。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fc738ce106c9173e3b5b93bf435f87f7\" tg-width=\"700\" tg-height=\"644\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> In the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.</p><p><blockquote>在周三发布的最新预测中,最鹰派的成员将2023年底的中期预测从1.63%温和上调至2.13%,2024年底从2.63%上调至3.13%。五位最鹰派的成员现在认为,美联储将不得不将联邦基金利率推高至2.5%的假设长期均衡水平之上。</blockquote></p><p> But the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.</p><p><blockquote>但是鸽派彻底撕毁了他们之前的预测。五位最鸽派的成员此前预测,到2023年底,加息幅度将在零到两次之间,但现在他们预计加息四到五次。到2024年底,他们一直预测加息两到四次;现在他们预计是七个。</blockquote></p><p> Clearly, even the most dovish Fed officials now believe the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.</p><p><blockquote>显然,即使是最鸽派的美联储官员现在也认为,联邦基金利率必须大幅上升才能战胜通胀。以前,他们认为通货膨胀会自行下降。</blockquote></p><p> This means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.</p><p><blockquote>这意味着通货膨胀不再受益。它被证明是有罪的,即使是鸽派也会继续战争,直到取得胜利。对于美联储通胀鸽派来说,2021年11月10日有点像1941年12月7日:是时候开战了。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAll the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-12-16 10:20</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out</p><p><blockquote>美联储制定了一条全新的路线来打击通胀,而不是继续等待通胀结束</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ba1b24817095f66e1cbf69b3dd7a4ad8\" tg-width=\"700\" tg-height=\"399\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.</p><p><blockquote>美联储周三会议的重大消息并不是它将停止购买债券来刺激经济,也不是它现在暗示将在2022年三次上调基准贷款利率。过去一个月,美联储官员已经充分传达了这些短期政策决定。</blockquote></p><p> No, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.</p><p><blockquote>不,最令人惊讶的是,庞大的、厌恶变革的美联储对通胀的看法发生了180度的转变。</blockquote></p><p> The Fed’s statement Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.</p><p><blockquote>美联储周三的声明和附带的材料表明,鸽派——普遍认为通胀风险被夸大的政策制定者——已经完全投降。现在每个人都是鹰。美联储已经没有鸽派了。</blockquote></p><p> Fed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.</p><p><blockquote>美联储货币政策制定者一致认为,对抗通胀是他们的首要任务。他们可能在策略或时机上存在分歧,但在尽快战胜通胀的策略上却没有分歧。美联储处于战争状态,通胀是敌人。</blockquote></p><p> For 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.</p><p><blockquote>30年来,鸽派一直是对的:通货膨胀不是经济的最大威胁;失业是。鸽派打了一场最终成功的战斗,迫使美联储考虑失业给社会和经济留下的许多个人带来的非常真实的成本。</blockquote></p><p> But now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.</p><p><blockquote>但现在,冠状病毒大流行的影响甚至迫使鸽派接受通胀是比失业更大的威胁。对于一个不喜欢变化的机构来说,这是一个巨大的变化。</blockquote></p><p> How do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.</p><p><blockquote>我们怎么知道鸽子已经变成鹰了?看看点阵图,这是美联储每三个月发布一次的图表,显示了每个货币政策制定者对未来几年底联邦基金利率水平的匿名个人预测。</blockquote></p><p> Most analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.</p><p><blockquote>大多数分析师正确地关注来年的预测中值,但我想将您的注意力简要地转移到异常值(美联储最鹰派和鸽派成员)的中期预测上,以显示战场有多大自11月10日可怕的消费者价格指数数据以来,美联储内部发生了变化。那份报告改变了美联储的一切。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fc738ce106c9173e3b5b93bf435f87f7\" tg-width=\"700\" tg-height=\"644\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> In the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.</p><p><blockquote>在周三发布的最新预测中,最鹰派的成员将2023年底的中期预测从1.63%温和上调至2.13%,2024年底从2.63%上调至3.13%。五位最鹰派的成员现在认为,美联储将不得不将联邦基金利率推高至2.5%的假设长期均衡水平之上。</blockquote></p><p> But the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.</p><p><blockquote>但是鸽派彻底撕毁了他们之前的预测。五位最鸽派的成员此前预测,到2023年底,加息幅度将在零到两次之间,但现在他们预计加息四到五次。到2024年底,他们一直预测加息两到四次;现在他们预计是七个。</blockquote></p><p> Clearly, even the most dovish Fed officials now believe the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.</p><p><blockquote>显然,即使是最鸽派的美联储官员现在也认为,联邦基金利率必须大幅上升才能战胜通胀。以前,他们认为通货膨胀会自行下降。</blockquote></p><p> This means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.</p><p><blockquote>这意味着通货膨胀不再受益。它被证明是有罪的,即使是鸽派也会继续战争,直到取得胜利。对于美联储通胀鸽派来说,2021年11月10日有点像1941年12月7日:是时候开战了。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.marketwatch.com/story/all-the-doves-at-the-fed-have-become-hawks-11639613760?mod=mw_latestnews\">MarketWatch</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/all-the-doves-at-the-fed-have-become-hawks-11639613760?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172070133","content_text":"The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out\n\nThe big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.\nNo, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.\nThe Fed’s statement Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.\nFed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.\nFor 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.\nBut now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.\nHow do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.\nMost analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.\n\nIn the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.\nBut the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.\nClearly, even the most dovish Fed officials now believe the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.\nThis means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":3827,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607695836,"gmtCreate":1639530829485,"gmtModify":1639530829588,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607695836","repostId":"1129773083","repostType":4,"isVote":1,"tweetType":1,"viewCount":3827,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604472686,"gmtCreate":1639442680885,"gmtModify":1639442680992,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604472686","repostId":"2191811539","repostType":4,"isVote":1,"tweetType":1,"viewCount":3311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604675566,"gmtCreate":1639395534696,"gmtModify":1639395534808,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604675566","repostId":"1131710846","repostType":4,"repost":{"id":"1131710846","kind":"news","pubTimestamp":1639393441,"share":"https://www.laohu8.com/m/news/1131710846?lang=zh_CN&edition=full","pubTime":"2021-12-13 19:04","market":"us","language":"en","title":"Stock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1131710846","media":"WSJ","summary":"U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank dec","content":"<p>U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p><p><blockquote>美国股指期货显示,在主要经济体央行决策繁忙的一周之前,主要股指涨幅温和。</blockquote></p><p> Futures for the S&P 500 rose 0.2% Monday, after the benchmark gauge closed last week at its67th record high of 2021. Contracts for the Dow Jones Industrial Average, which sits just shy of an all-time high, also ticked up 0.2%, as did futures for the technology-heavy Nasdaq-100.</p><p><blockquote>标普500期货周一上涨0.2%,此前该基准指数上周收于2021年第67次历史新高。接近历史高点的道琼斯工业平均指数合约也上涨0.2%,以科技股为主的纳斯达克100指数期货也上涨0.2%。</blockquote></p><p> In the bond market, the yield on benchmark 10-year Treasury notes ticked up to 1.492% Monday from 1.487% Friday. Yields move in the opposite direction to bond prices.</p><p><blockquote>在债券市场,基准10年期国债收益率从周五的1.487%升至周一的1.492%。收益率的变动方向与债券价格相反。</blockquote></p><p> Investors are sitting tight ahead of a monetary-policy decision by the Federal Reserve and announcements from the Bank of England, European Central Bank and Bank of Japan later in the week. The Fed is expected to accelerate the pace at which it is paring its bond-buying program and to signal that it will raise interest rates next year to tap the brakes on inflation. Data published Friday showed consumer prices increased in November at the fastest annual rate since 1982.</p><p><blockquote>投资者对美联储的货币政策决定以及英国央行、欧洲央行和日本央行本周晚些时候的公告持观望态度。预计美联储将加快削减债券购买计划的步伐,并暗示明年将加息以抑制通胀。周五公布的数据显示,11月份消费者价格以1982年以来最快的年增长率上涨。</blockquote></p><p> Gregory Perdon, co-chief investment officer at Arbuthnot Latham,said he expects stocks to keep rising even as the Fed tightens monetary policy.</p><p><blockquote>Arbuthnot Latham联席首席投资官Gregory Perdon表示,即使美联储收紧货币政策,他预计股市仍将继续上涨。</blockquote></p><p> “The classic textbook would be rates up, stocks down,” Mr. Perdon said. “The reality is there’s so much liquidity out there, there’s so much demand to get a return on assets that ultimately we’re going to have to have a much…more aggressive tightening to knock stocks.”</p><p><blockquote>“经典的教科书是利率上升,股票下跌,”珀登先生说。“现实情况是,流动性如此之多,获得资产回报的需求如此之大,最终我们将不得不采取……更激进的紧缩措施来打击股市。”</blockquote></p><p> Commodity prices rose. Brent-crude futures, the benchmark in international energy markets, ticked up 0.5% to $75.53 a barrel. Prices snapped a six-week losing streak Friday, recovering some ground shed when the Omicron variant threatened to hit oil demand.</p><p><blockquote>大宗商品价格上涨。国际能源市场基准布伦特原油期货上涨0.5%,至每桶75.53美元。周五,油价结束了连续六周的下跌,收复了奥密克戎变种威胁打击石油需求时的一些下跌。</blockquote></p><p> European natural-gas prices jumped more than 8% Monday. Supplies of gas, a key heating and power-generation fuel in Europe, are well below their recent average for the time of year, raising concerns stockpiles will run low as cold weather lifts demand. U.S. natural-gas futures rose 1.9% to $4 per million British thermal units.</p><p><blockquote>欧洲天然气价格周一上涨超过8%。天然气是欧洲主要的供暖和发电燃料,其供应量远低于最近一年同期的平均水平,这引发了人们的担忧,即随着寒冷天气提振需求,库存将会减少。美国天然气期货上涨1.9%,至每百万英热单位4美元。</blockquote></p><p> Turkey’s lira slumped 4% to trade at 14.46 to the dollar ahead of an expected rate cut by the central bank on Thursday. The Central Bank of the Republic of Turkey has bowed to pressure from President Recep Tayyip Erdogan to lower borrowing costs this year in the face of rapid inflation, hitting the currency hard.</p><p><blockquote>在央行周四预期降息之前,土耳其里拉兑美元汇率下跌4%,至14.46里拉。面对快速通胀,土耳其共和国中央银行屈服于总统雷杰普·塔伊普·埃尔多安今年降低借贷成本的压力,对货币造成了沉重打击。</blockquote></p><p> Overseas stock markets were mixed. The Stoxx Europe 600 edged up 0.1%, led higher by shares of basic-resources, auto and oil-and-gas companies. Among individual movers,Vifor Pharmajumped more than 15% after the Swiss pharmaceutical firm said it was in talks to be bought by Australia’s CSL.</p><p><blockquote>海外股市涨跌互现。斯托克欧洲600指数小幅上涨0.1%,基础资源、汽车和石油天然气公司的股价领涨。在个别推动者中,瑞士制药公司Vifor Pharma表示正在就被澳大利亚CSL收购进行谈判后,该公司股价上涨超过15%。</blockquote></p><p> Japan’s Nikkei 225 rose 0.7%, the Shanghai Composite Index added 0.4% and Hong Kong’s Hang Seng slipped 0.2%.</p><p><blockquote>日本日经225指数上涨0.7%,上证综合指数上涨0.4%,香港恒生指数下跌0.2%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">WSJ</strong><span class=\"h-time small\">2021-12-13 19:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p>U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p><p><blockquote>美国股指期货显示,在主要经济体央行决策繁忙的一周之前,主要股指涨幅温和。</blockquote></p><p> Futures for the S&P 500 rose 0.2% Monday, after the benchmark gauge closed last week at its67th record high of 2021. Contracts for the Dow Jones Industrial Average, which sits just shy of an all-time high, also ticked up 0.2%, as did futures for the technology-heavy Nasdaq-100.</p><p><blockquote>标普500期货周一上涨0.2%,此前该基准指数上周收于2021年第67次历史新高。接近历史高点的道琼斯工业平均指数合约也上涨0.2%,以科技股为主的纳斯达克100指数期货也上涨0.2%。</blockquote></p><p> In the bond market, the yield on benchmark 10-year Treasury notes ticked up to 1.492% Monday from 1.487% Friday. Yields move in the opposite direction to bond prices.</p><p><blockquote>在债券市场,基准10年期国债收益率从周五的1.487%升至周一的1.492%。收益率的变动方向与债券价格相反。</blockquote></p><p> Investors are sitting tight ahead of a monetary-policy decision by the Federal Reserve and announcements from the Bank of England, European Central Bank and Bank of Japan later in the week. The Fed is expected to accelerate the pace at which it is paring its bond-buying program and to signal that it will raise interest rates next year to tap the brakes on inflation. Data published Friday showed consumer prices increased in November at the fastest annual rate since 1982.</p><p><blockquote>投资者对美联储的货币政策决定以及英国央行、欧洲央行和日本央行本周晚些时候的公告持观望态度。预计美联储将加快削减债券购买计划的步伐,并暗示明年将加息以抑制通胀。周五公布的数据显示,11月份消费者价格以1982年以来最快的年增长率上涨。</blockquote></p><p> Gregory Perdon, co-chief investment officer at Arbuthnot Latham,said he expects stocks to keep rising even as the Fed tightens monetary policy.</p><p><blockquote>Arbuthnot Latham联席首席投资官Gregory Perdon表示,即使美联储收紧货币政策,他预计股市仍将继续上涨。</blockquote></p><p> “The classic textbook would be rates up, stocks down,” Mr. Perdon said. “The reality is there’s so much liquidity out there, there’s so much demand to get a return on assets that ultimately we’re going to have to have a much…more aggressive tightening to knock stocks.”</p><p><blockquote>“经典的教科书是利率上升,股票下跌,”珀登先生说。“现实情况是,流动性如此之多,获得资产回报的需求如此之大,最终我们将不得不采取……更激进的紧缩措施来打击股市。”</blockquote></p><p> Commodity prices rose. Brent-crude futures, the benchmark in international energy markets, ticked up 0.5% to $75.53 a barrel. Prices snapped a six-week losing streak Friday, recovering some ground shed when the Omicron variant threatened to hit oil demand.</p><p><blockquote>大宗商品价格上涨。国际能源市场基准布伦特原油期货上涨0.5%,至每桶75.53美元。周五,油价结束了连续六周的下跌,收复了奥密克戎变种威胁打击石油需求时的一些下跌。</blockquote></p><p> European natural-gas prices jumped more than 8% Monday. Supplies of gas, a key heating and power-generation fuel in Europe, are well below their recent average for the time of year, raising concerns stockpiles will run low as cold weather lifts demand. U.S. natural-gas futures rose 1.9% to $4 per million British thermal units.</p><p><blockquote>欧洲天然气价格周一上涨超过8%。天然气是欧洲主要的供暖和发电燃料,其供应量远低于最近一年同期的平均水平,这引发了人们的担忧,即随着寒冷天气提振需求,库存将会减少。美国天然气期货上涨1.9%,至每百万英热单位4美元。</blockquote></p><p> Turkey’s lira slumped 4% to trade at 14.46 to the dollar ahead of an expected rate cut by the central bank on Thursday. The Central Bank of the Republic of Turkey has bowed to pressure from President Recep Tayyip Erdogan to lower borrowing costs this year in the face of rapid inflation, hitting the currency hard.</p><p><blockquote>在央行周四预期降息之前,土耳其里拉兑美元汇率下跌4%,至14.46里拉。面对快速通胀,土耳其共和国中央银行屈服于总统雷杰普·塔伊普·埃尔多安今年降低借贷成本的压力,对货币造成了沉重打击。</blockquote></p><p> Overseas stock markets were mixed. The Stoxx Europe 600 edged up 0.1%, led higher by shares of basic-resources, auto and oil-and-gas companies. Among individual movers,Vifor Pharmajumped more than 15% after the Swiss pharmaceutical firm said it was in talks to be bought by Australia’s CSL.</p><p><blockquote>海外股市涨跌互现。斯托克欧洲600指数小幅上涨0.1%,基础资源、汽车和石油天然气公司的股价领涨。在个别推动者中,瑞士制药公司Vifor Pharma表示正在就被澳大利亚CSL收购进行谈判后,该公司股价上涨超过15%。</blockquote></p><p> Japan’s Nikkei 225 rose 0.7%, the Shanghai Composite Index added 0.4% and Hong Kong’s Hang Seng slipped 0.2%.</p><p><blockquote>日本日经225指数上涨0.7%,上证综合指数上涨0.4%,香港恒生指数下跌0.2%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-13-2021-11639384564?mod=hp_lead_pos1\">WSJ</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-13-2021-11639384564?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131710846","content_text":"U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.\nFutures for the S&P 500 rose 0.2% Monday, after the benchmark gauge closed last week at its67th record high of 2021. Contracts for the Dow Jones Industrial Average, which sits just shy of an all-time high, also ticked up 0.2%, as did futures for the technology-heavy Nasdaq-100.\nIn the bond market, the yield on benchmark 10-year Treasury notes ticked up to 1.492% Monday from 1.487% Friday. Yields move in the opposite direction to bond prices.\nInvestors are sitting tight ahead of a monetary-policy decision by the Federal Reserve and announcements from the Bank of England, European Central Bank and Bank of Japan later in the week. The Fed is expected to accelerate the pace at which it is paring its bond-buying program and to signal that it will raise interest rates next year to tap the brakes on inflation. Data published Friday showed consumer prices increased in November at the fastest annual rate since 1982.\nGregory Perdon, co-chief investment officer at Arbuthnot Latham,said he expects stocks to keep rising even as the Fed tightens monetary policy.\n“The classic textbook would be rates up, stocks down,” Mr. Perdon said. “The reality is there’s so much liquidity out there, there’s so much demand to get a return on assets that ultimately we’re going to have to have a much…more aggressive tightening to knock stocks.”\nCommodity prices rose. Brent-crude futures, the benchmark in international energy markets, ticked up 0.5% to $75.53 a barrel. Prices snapped a six-week losing streak Friday, recovering some ground shed when the Omicron variant threatened to hit oil demand.\nEuropean natural-gas prices jumped more than 8% Monday. Supplies of gas, a key heating and power-generation fuel in Europe, are well below their recent average for the time of year, raising concerns stockpiles will run low as cold weather lifts demand. U.S. natural-gas futures rose 1.9% to $4 per million British thermal units.\nTurkey’s lira slumped 4% to trade at 14.46 to the dollar ahead of an expected rate cut by the central bank on Thursday. The Central Bank of the Republic of Turkey has bowed to pressure from President Recep Tayyip Erdogan to lower borrowing costs this year in the face of rapid inflation, hitting the currency hard.\nOverseas stock markets were mixed. The Stoxx Europe 600 edged up 0.1%, led higher by shares of basic-resources, auto and oil-and-gas companies. Among individual movers,Vifor Pharmajumped more than 15% after the Swiss pharmaceutical firm said it was in talks to be bought by Australia’s CSL.\nJapan’s Nikkei 225 rose 0.7%, the Shanghai Composite Index added 0.4% and Hong Kong’s Hang Seng slipped 0.2%.","news_type":1,"symbols_score_info":{".IXIC":0.9,"BZmain":0.9,".DJI":0.9,".SPX":0.9,"NQmain":0.9,"ESmain":0.9,"CLmain":0.9,"YMmain":0.9}},"isVote":1,"tweetType":1,"viewCount":3697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604301439,"gmtCreate":1639325093032,"gmtModify":1639325093141,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/604301439","repostId":"2190719536","repostType":4,"isVote":1,"tweetType":1,"viewCount":3443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605624338,"gmtCreate":1639155725026,"gmtModify":1639155782282,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"title":"","htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605624338","repostId":"1165282830","repostType":4,"repost":{"id":"1165282830","kind":"news","pubTimestamp":1639148461,"share":"https://www.laohu8.com/m/news/1165282830?lang=zh_CN&edition=full","pubTime":"2021-12-10 23:01","market":"us","language":"en","title":"Tesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1165282830","media":"Electrek","summary":"Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outs","content":"<p>Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outside North America.</p><p><blockquote>特斯拉今天向潜在买家宣布,停止接受北美以外的新Model S和Model X订单。</blockquote></p><p> It now expects deliveries in other markets to start during the second half of 2022.</p><p><blockquote>目前预计其他市场的交付将于2022年下半年开始。</blockquote></p><p> The news comes from an email that Tesla started sending out to people who have Model S and Model X vehicles on order in Europe.</p><p><blockquote>该消息来自特斯拉开始向在欧洲订购Model S和Model X车辆的人发送的一封电子邮件。</blockquote></p><p> Tesla writes in the email that it is not accepting any new orders (translated from German):</p><p><blockquote>特斯拉在电子邮件中写道,它不接受任何新订单(翻译自德语):</blockquote></p><p> In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America. This is in response to Tesla likely having a large backlog of Model S/X orders in Europe and other markets, where there has been no new Model S/X shipment in a year.</p><p><blockquote>为了尽可能加快现有订单(包括您的Model X订单)的交付,我们目前不再接受来自北美以外市场的Model S和Model X的新订单。这是为了应对特斯拉可能在欧洲和其他市场积压了大量Model S/X订单,这些市场已经一年没有新的Model S/X出货量了。</blockquote></p><p> Tesla shut down Model S and Model X production in January of last year to update the vehicles.</p><p><blockquote>特斯拉于去年1月关闭了Model S和Model X的生产以更新车辆。</blockquote></p><p> During that year, the automaker kept taking new orders, but production was delayed with new Model S starting to slowly come off the assembly line in June and Model X in October.</p><p><blockquote>那一年,该汽车制造商不断接受新订单,但生产被推迟,新款Model S于6月开始慢慢下线,Model X于10月开始下线。</blockquote></p><p> Tesla is still catching up to the backlog in North America while new orders kept coming in from Europe and Asia.</p><p><blockquote>特斯拉仍在追赶北美的积压订单,而新订单不断来自欧洲和亚洲。</blockquote></p><p> In the email, Tesla says that it now aims to deliver the first Model S and Model X in Europe during the second half of next year:</p><p><blockquote>特斯拉在电子邮件中表示,目前的目标是明年下半年在欧洲交付首批Model S和Model X:</blockquote></p><p> Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022. This means that Europe would be without Model S and Model X for a year and a half.</p><p><blockquote>你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。这意味着欧洲将有一年半的时间没有Model S和Model X。</blockquote></p><p> Here’s the email in full:</p><p><blockquote>以下是电子邮件全文:</blockquote></p><p> Hello [redacted], We are contacting you regarding the timing of your Model X order. As we expand production capacity, the launch dates for markets outside of North America have been postponed. We will inform you of the delivery times through your Tesla account when production begins. Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022. In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America. The price of your Model X will continue to be the same as it was when you placed your order, unless your vehicle configuration has been changed. To apply your order fee to another model, or to receive a full refund, request a call to speak directly to a Tesla representative. We apologize for any inconvenience this may cause. Kind regards, Your Tesla Team Testa </p><p><blockquote>您好【已编辑】,我们正在就您订购Model X的时间与您联系。随着我们扩大产能,北美以外市场的上市日期已经推迟。当生产开始时,我们将通过您的特斯拉帐户通知您交货时间。你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。为了尽可能加快现有订单(包括您的Model X订单)的交付,我们目前不再接受来自北美以外市场的Model S和Model X的新订单。您的Model X的价格将继续与您下订单时相同,除非您的车辆配置发生了变化。要将您的订单费用应用于其他型号,或获得全额退款,请要求看涨期权直接与特斯拉代表联系。对于由此可能造成的任何不便,我们深表歉意。亲切的问候,您的特斯拉团队Testa</blockquote></p><p></p>","source":"lsy1627037122897","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Electrek</strong><span class=\"h-time small\">2021-12-10 23:01</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outside North America.</p><p><blockquote>特斯拉今天向潜在买家宣布,停止接受北美以外的新Model S和Model X订单。</blockquote></p><p> It now expects deliveries in other markets to start during the second half of 2022.</p><p><blockquote>目前预计其他市场的交付将于2022年下半年开始。</blockquote></p><p> The news comes from an email that Tesla started sending out to people who have Model S and Model X vehicles on order in Europe.</p><p><blockquote>该消息来自特斯拉开始向在欧洲订购Model S和Model X车辆的人发送的一封电子邮件。</blockquote></p><p> Tesla writes in the email that it is not accepting any new orders (translated from German):</p><p><blockquote>特斯拉在电子邮件中写道,它不接受任何新订单(翻译自德语):</blockquote></p><p> In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America. This is in response to Tesla likely having a large backlog of Model S/X orders in Europe and other markets, where there has been no new Model S/X shipment in a year.</p><p><blockquote>为了尽可能加快现有订单(包括您的Model X订单)的交付,我们目前不再接受来自北美以外市场的Model S和Model X的新订单。这是为了应对特斯拉可能在欧洲和其他市场积压了大量Model S/X订单,这些市场已经一年没有新的Model S/X出货量了。</blockquote></p><p> Tesla shut down Model S and Model X production in January of last year to update the vehicles.</p><p><blockquote>特斯拉于去年1月关闭了Model S和Model X的生产以更新车辆。</blockquote></p><p> During that year, the automaker kept taking new orders, but production was delayed with new Model S starting to slowly come off the assembly line in June and Model X in October.</p><p><blockquote>那一年,该汽车制造商不断接受新订单,但生产被推迟,新款Model S于6月开始慢慢下线,Model X于10月开始下线。</blockquote></p><p> Tesla is still catching up to the backlog in North America while new orders kept coming in from Europe and Asia.</p><p><blockquote>特斯拉仍在追赶北美的积压订单,而新订单不断来自欧洲和亚洲。</blockquote></p><p> In the email, Tesla says that it now aims to deliver the first Model S and Model X in Europe during the second half of next year:</p><p><blockquote>特斯拉在电子邮件中表示,目前的目标是明年下半年在欧洲交付首批Model S和Model X:</blockquote></p><p> Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022. This means that Europe would be without Model S and Model X for a year and a half.</p><p><blockquote>你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。这意味着欧洲将有一年半的时间没有Model S和Model X。</blockquote></p><p> Here’s the email in full:</p><p><blockquote>以下是电子邮件全文:</blockquote></p><p> Hello [redacted], We are contacting you regarding the timing of your Model X order. As we expand production capacity, the launch dates for markets outside of North America have been postponed. We will inform you of the delivery times through your Tesla account when production begins. Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022. In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America. The price of your Model X will continue to be the same as it was when you placed your order, unless your vehicle configuration has been changed. To apply your order fee to another model, or to receive a full refund, request a call to speak directly to a Tesla representative. We apologize for any inconvenience this may cause. Kind regards, Your Tesla Team Testa </p><p><blockquote>您好【已编辑】,我们正在就您订购Model X的时间与您联系。随着我们扩大产能,北美以外市场的上市日期已经推迟。当生产开始时,我们将通过您的特斯拉帐户通知您交货时间。你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。为了尽可能加快现有订单(包括您的Model X订单)的交付,我们目前不再接受来自北美以外市场的Model S和Model X的新订单。您的Model X的价格将继续与您下订单时相同,除非您的车辆配置发生了变化。要将您的订单费用应用于其他型号,或获得全额退款,请要求看涨期权直接与特斯拉代表联系。对于由此可能造成的任何不便,我们深表歉意。亲切的问候,您的特斯拉团队Testa</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://electrek.co/2021/12/10/tesla-stops-taking-model-s-x-orders-outside-north-america/\">Electrek</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://electrek.co/2021/12/10/tesla-stops-taking-model-s-x-orders-outside-north-america/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165282830","content_text":"Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outside North America.\nIt now expects deliveries in other markets to start during the second half of 2022.\nThe news comes from an email that Tesla started sending out to people who have Model S and Model X vehicles on order in Europe.\nTesla writes in the email that it is not accepting any new orders (translated from German):\n\n In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.\n\nThis is in response to Tesla likely having a large backlog of Model S/X orders in Europe and other markets, where there has been no new Model S/X shipment in a year.\nTesla shut down Model S and Model X production in January of last year to update the vehicles.\nDuring that year, the automaker kept taking new orders, but production was delayed with new Model S starting to slowly come off the assembly line in June and Model X in October.\nTesla is still catching up to the backlog in North America while new orders kept coming in from Europe and Asia.\nIn the email, Tesla says that it now aims to deliver the first Model S and Model X in Europe during the second half of next year:\n\n Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.\n\nThis means that Europe would be without Model S and Model X for a year and a half.\nHere’s the email in full:\n\n Hello [redacted],\n\n\n We are contacting you regarding the timing of your Model X order. As we expand production capacity, the launch dates for markets outside of North America have been postponed. We will inform you of the delivery times through your Tesla account when production begins.\n\n\n Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.\n\n\n In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.\n\n\n The price of your Model X will continue to be the same as it was when you placed your order, unless your vehicle configuration has been changed. To apply your order fee to another model, or to receive a full refund, request a call to speak directly to a Tesla representative.\n\n\n We apologize for any inconvenience this may cause.\n\n\n Kind regards,\n\n\n Your Tesla Team Testa","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":4004,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}